"iPSCs are human cells grown in the lab, that have been reprogrammed so they can develop into all cell types of our body. The technique offers tremendous potential for future therapies as they provide an unlimited supply of cells that can be turned into a desired cell or tissue type."
Correct, but unfortunately that is why this is 20 years away.
In the mean time MSB soars.
- Forums
- ASX - By Stock
- CYP
- Ann: First Kidney Transplant Trial Patient Treated
CYP
cynata therapeutics limited
Add to My Watchlist
9.68%
!
17.0¢

Ann: First Kidney Transplant Trial Patient Treated, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.0¢ | 16.0¢ | $29.83K | 183.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 219467 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 26941 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 219467 | 0.155 |
7 | 403545 | 0.150 |
5 | 106775 | 0.145 |
4 | 29291 | 0.140 |
1 | 5000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 26941 | 1 |
0.175 | 113371 | 3 |
0.180 | 165059 | 2 |
0.185 | 25916 | 1 |
0.195 | 6764 | 2 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online